# Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

> **NCT00300222** · PHASE3 · COMPLETED · sponsor: **NeurogesX** · enrollment: 400 (—)

## Conditions studied

- Peripheral Nervous System Diseases
- Pain
- Neuralgia
- Herpes Zoster
- Shingles

## Interventions

- **DRUG:** NGX-4010

## Key facts

- **NCT ID:** NCT00300222
- **Lead sponsor:** NeurogesX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 400 (—)
- **Last updated:** 2008-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00300222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00300222, "Study of NGX-4010 for the Treatment of Postherpetic Neuralgia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00300222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*